BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Since the beginning of President Donald J. Trump’s second term, an unprecedented wave of private investment announcements has poured into American ...

Mario Gabelli needs no introduction, having risen to become one of the most successful money managers on Wall Street, backed ...

We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this ...

SonoVascular, a Chapel Hill medical device startup focusing on treating potentially life-threatening blood clots, has earned the top life sciences award from the Angel Capital Association.

Regeneron, which makes drugs for skin and respiratory diseases, is doubling its U.S. manufacturing capacity in a new $3 billion, 10-year agreement with Fujifilm Diosynth Biotechnologies.

At Amgen North Carolina, we see the apprenticeship program we developed in partnership with Wake Tech Community College, as a ...

It has suggested that suppliers like Lonza, Thermo Fisher Scientific, Catalent, and Fujifilm Diosynth Biotechnologies are looking at ramping up capacity to serve companies that look to reshore ...

RoosterBio, a supplier of adult human mesenchymal stem/stromal cells (hMSCs), engineered media, and bioprocess development services, entered into a collaboration with Thermo Fisher Scientific ...

GSK has said that its chief financial officer Iain Mackay will stand down from the role in May next year, to be replaced by Julie Brown, currently chief operating and financial officer at luxury ...